Pilot Study to Evaluate Subcutaneous Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background- a Pilot, Double-blind, Placebo-controlled, Randomized, Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2018
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 08 Jun 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
- 08 Jun 2018 Planned primary completion date changed from 1 Dec 2016 to 30 Jun 2018.
- 18 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.